63323-578-01 |
63323-578 |
HUMAN PRESCRIPTION DRUG |
Glycopyrrolate |
Glycopyrrolate |
INJECTION, SOLUTION |
INTRAMUSCULAR; INTRAVENOUS |
20171027 |
N/A |
ANDA |
ANDA209328 |
Fresenius Kabi USA, LLC |
GLYCOPYRROLATE |
.2 mg/mL |
25 VIAL, SINGLE-DOSE in 1 CARTON (63323-578-01) / 1 mL in 1 VIAL, SINGLE-DOSE (63323-578-03) |
63323-578-02 |
63323-578 |
HUMAN PRESCRIPTION DRUG |
Glycopyrrolate |
Glycopyrrolate |
INJECTION, SOLUTION |
INTRAMUSCULAR; INTRAVENOUS |
20171027 |
N/A |
ANDA |
ANDA209328 |
Fresenius Kabi USA, LLC |
GLYCOPYRROLATE |
.2 mg/mL |
25 VIAL, SINGLE-DOSE in 1 CARTON (63323-578-02) / 2 mL in 1 VIAL, SINGLE-DOSE (63323-578-04) |
63323-578-05 |
63323-578 |
HUMAN PRESCRIPTION DRUG |
Glycopyrrolate |
Glycopyrrolate |
INJECTION, SOLUTION |
INTRAMUSCULAR; INTRAVENOUS |
20171027 |
N/A |
ANDA |
ANDA209328 |
Fresenius Kabi USA, LLC |
GLYCOPYRROLATE |
.2 mg/mL |
25 VIAL, MULTI-DOSE in 1 CARTON (63323-578-05) / 5 mL in 1 VIAL, MULTI-DOSE (63323-578-07) |
65219-801-01 |
65219-801 |
HUMAN PRESCRIPTION DRUG |
Glycopyrrolate |
Glycopyrrolate |
INJECTION, SOLUTION |
INTRAMUSCULAR; INTRAVENOUS |
20231231 |
N/A |
ANDA |
ANDA209328 |
Fresenius Kabi USA, LLC |
GLYCOPYRROLATE |
.2 mg/mL |
25 VIAL, SINGLE-DOSE in 1 CARTON (65219-801-01) / 1 mL in 1 VIAL, SINGLE-DOSE (65219-801-00) |
63323-578-11 |
63323-578 |
HUMAN PRESCRIPTION DRUG |
Glycopyrrolate |
Glycopyrrolate |
INJECTION, SOLUTION |
INTRAMUSCULAR; INTRAVENOUS |
20171027 |
N/A |
ANDA |
ANDA209328 |
Fresenius Kabi USA, LLC |
GLYCOPYRROLATE |
.2 mg/mL |
25 VIAL, SINGLE-DOSE in 1 CARTON (63323-578-11) / 1 mL in 1 VIAL, SINGLE-DOSE (63323-578-41) |
63323-578-12 |
63323-578 |
HUMAN PRESCRIPTION DRUG |
Glycopyrrolate |
Glycopyrrolate |
INJECTION, SOLUTION |
INTRAMUSCULAR; INTRAVENOUS |
20171027 |
N/A |
ANDA |
ANDA209328 |
Fresenius Kabi USA, LLC |
GLYCOPYRROLATE |
.2 mg/mL |
25 VIAL, SINGLE-DOSE in 1 CARTON (63323-578-12) / 2 mL in 1 VIAL, SINGLE-DOSE (63323-578-42) |